Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.245 USD | -0.15% | -2.98% | +17.69% |
May. 14 | Transcript : Cellectar Biosciences, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Cellectar Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.69% | 117M | |
+37.51% | 723B | |
+32.22% | 598B | |
-1.75% | 364B | |
+20.47% | 331B | |
+3.80% | 288B | |
+16.60% | 244B | |
+9.77% | 210B | |
-5.15% | 208B | |
+8.84% | 169B |
- Stock Market
- Equities
- CLRB Stock
- News Cellectar Biosciences, Inc.
- Transcript : Cellectar Biosciences, Inc. Presents at BIO CEO & Investor Digital Conference 2021, Feb-16-2021